Goldline Pharma: Executive Director Acquires 0.28% Stake

Prashant Shrikrishna Karkare, an Executive Director at Goldline Pharmaceutical Ltd, has acquired 27,000 equity shares, representing 0.28% of the company's total issued and paid-up share capital. The acquisition was made through open market purchases on July 28, 2026. This disclosure is made in compliance with Regulation 29(2) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. The total issued share capital remains 9,600,000 equity shares post-acquisition.